TC |
Stat |
Stk |
Ins |
Fil |
+d |
+w |
+m |
+q |
+h |
+y |
avg |
|---|
Filing Date |
T Date |
Ticker |
Issuer | Inc | Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/20/25 17:20 | 10/16/25 | XGN | Exagen Inc. | DE | Health | Health | Medical Laboratories | Aballi John | CA | DO | P,CEO | S | -376 | 11.82 | 0 | -32 | -4 | 755 | D | ||||||||||||||
11/18/24 18:32 | 11/14/24 | XGN | Exagen Inc. | DE | Health | Health | Medical Laboratories | Aballi John | CA | DO | P,CEO | P | 68 | 2.81 | 0 | 24 | 4 | 690 | D | ||||||||||||||
5/16/24 20:02 | 5/16/24 | XGN | Exagen Inc. | DE | Health | Health | Medical Laboratories | Aballi John | CA | DO | P,CEO | P | 78 | 1.92 | 0 | 40 | 7 | 641 | I | ||||||||||||||
10/18/23 16:05 | 10/17/23 | XGN | Exagen Inc. | DE | Health | Health | Medical Laboratories | Aballi John | CA | DO | P,CEO | S | -59 | 1.75 | 0 | -34 | -8 | 416 | D | ||||||||||||||
12/9/22 09:00 | 12/8/22 | XGN | Exagen Inc. | DE | Health | Health | Medical Laboratories | Aballi John | CA | DO | P,CEO | P | 241 | 2.68 | 0 | 90 | 26 | 440 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |